Analyst Recommendations
248.86 1.25(0.50%)07/03/2024
Alnylam Pharmaceuticals Inc (ALNY)
Alnylam Pharmaceuticals Inc (ALNY)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 15 |
Neutral | 9 |
Outperform | 9 |
Equal-Weight | 4 |
Market Perform | 1 |
Overweight | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades